Cargando…
Combined Delivery of Paclitaxel and Tanespimycin via Micellar Nanocarriers: Pharmacokinetics, Efficacy and Metabolomic Analysis
BACKGROUND: Despite the promising anticancer efficacy observed in preclinical studies, paclitaxel and tanespimycin (17-AAG) combination therapy has yielded meager responses in a phase I clinical trial. One serious problem associated with paclitaxel/17-AAG combination therapy is the employment of lar...
Autores principales: | Katragadda, Usha, Fan, Wei, Wang, Yingzhe, Teng, Quincy, Tan, Chalet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591361/ https://www.ncbi.nlm.nih.gov/pubmed/23505544 http://dx.doi.org/10.1371/journal.pone.0058619 |
Ejemplares similares
-
Enhanced Tumor Delivery of Gemcitabine via PEG-DSPE/TPGS
Mixed Micelles
por: Wang, Yingzhe, et al.
Publicado: (2014) -
A Chitosan-Based Micellar System as Nanocarrier For the Delivery of Paclitaxel
por: Han, Yang, et al.
Publicado: (2020) -
Systemic Protein Delivery via Inhalable Liposomes: Formulation and Pharmacokinetics
por: Ponkshe, Pranav, et al.
Publicado: (2023) -
Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies
por: Tan, Chalet, et al.
Publicado: (2013) -
Tipifarnib and tanespimycin show synergic proapoptotic activity in U937 cells
por: Krzykowska-Petitjean, Katarzyna, et al.
Publicado: (2011)